Summit Therapeutics plc (SMMT): Price and Financial Metrics
SMMT Price/Volume Stats
| Current price | $25.41 | 52-week high | $36.91 |
| Prev. close | $24.39 | 52-week low | $2.10 |
| Day low | $23.88 | Volume | 4,409,300 |
| Day high | $26.85 | Avg. volume | 3,447,070 |
| 50-day MA | $22.77 | Dividend yield | N/A |
| 200-day MA | $19.88 | Market Cap | 18.87B |
SMMT Stock Price Chart Interactive Chart >
Summit Therapeutics plc (SMMT) Company Bio
Summit Therapeutics plc operates as a biopharmaceutical company primarily in the United Kingdom and the Unites States. It focuses on the discovery, development, and commercialization of novel medicines to treat the Duchenne Muscular Dystrophy (DMD), a fatal muscle wasting disease; and infections caused by Clostridium difficile bacteria (CDI). The company was founded in 2003 and is based in Abingdon, England.
SMMT Price Returns
| 1-mo | -7.09% |
| 3-mo | 14.87% |
| 6-mo | 33.74% |
| 1-year | 478.82% |
| 3-year | 2,531.80% |
| 5-year | 515.25% |
| YTD | 42.39% |
| 2024 | 583.72% |
| 2023 | -38.59% |
| 2022 | 57.99% |
| 2021 | -42.77% |
| 2020 | 193.75% |
Continue Researching SMMT
Here are a few links from around the web to help you further your research on Summit Therapeutics plc's stock as an investment opportunity:Summit Therapeutics plc (SMMT) Stock Price | Nasdaq
Summit Therapeutics plc (SMMT) Stock Quote, History and News - Yahoo Finance
Summit Therapeutics plc (SMMT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...